Dose-response curves measuring cAMP production showed that all five obesity-associated human mutations in EL1, and point-to-point contact mutations in TM2 and TM3 significantly reduced α-MSH-mediated activation (Fig. 3A). This evidence concerns the gene STAMBP and obesity due to melanocortin 4 receptor deficiency.